McDermott Will & Emery advised Corteria Pharmaceuticals on the deal. Corteria Pharmaceuticals, a French biotechnology company specializing in the development of interceptive therapies for heart failure...
McDermott Will & Emery advised Corteria Pharmaceuticals on the deal. Corteria Pharmaceuticals, a French biotechnology company specializing in the development of interceptive therapies for heart failure...
You must be a Standard 1 Year member to access this content.